Mycobacterium tuberculosis has innate resistance to a range of broad-spectrum antimicrobial agents. This may in part reflect the relative impermeability of the mycobacterial cell wall, but additional specific mechanisms may also be important. In the case of fosfomycin, it has been suggested that a key difference in the active site of the M. tuberculosis MurA enzyme might confer resistance. In Escherichia coli, fosfomycin covalently binds to a cysteine normally involved in the enzymic activity, while protein alignments predict an aspartate at this position in the M. tuberculosis MurA. In the present study, it is demonstrated that the wild-type M. tuberculosis MurA is indeed resistant to fosfomycin, and that it becomes sensitive following replacement of the aspartate residue in position 117 by a cysteine. In addition, the study illustrates the use of an inducible expression system in mycobacteria to allow functional characterization of an M. tuberculosis enzyme that is unstable during constitutive expression.
AinsaJ. A., PerezE., PelicicV., BerthetF. X., GicquelB., MartinC.1997; Aminoglycoside 2′-N-acetyltransferase genes are universally present in mycobacteria: characterization of the aac(2′)-Ic gene from Mycobacterium tuberculosis and the aac(2′)-Id gene from Mycobacterium smegmatis. Mol Microbiol 24:431–441[CrossRef]
ArcaP., RegueraG., HardissonC.1997; Plasmid-encoded fosfomycin resistance in bacteria isolated from the urinary tract in a multicentre survey. J Antimicrob Chemother 40:393–399[CrossRef]
AshbridgeK. R., BoothR. J., WatsonJ. D., LathigraR. B.1989; Nucleotide sequence of the 19 kDa antigen gene from Mycobacterium tuberculosis. Nucleic Acids Res 17:1249[CrossRef]
BardarovS., KriakovJ., CarriereC., YuS., VaamondeC., McAdamR. A., BloomB. R., HatfullG. F., JacobsW. R.Jr1997; Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobacterium tuberculosis. Proc Natl Acad Sci USA 94:10961–10966[CrossRef]
BoshoffH. I., MizrahiV.1998; Purification, gene cloning, targeted knockout, overexpression, and biochemical characterization of the major pyrazinamidase from Mycobacterium smegmatis. J Bacteriol 180:5809–5814
ColeS. T., BroschR., ParkhillJ.39 other authors1998; Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537–544[CrossRef]
GarbeT. R., BarathiJ., BarniniS., ZhangY., Abou ZeidC., TangD., MukherjeeR., YoungD. B.1994; Transformation of mycobacterial species using hygromycin resistance as selectable marker. Microbiology 140:133–138[CrossRef]
HendlinD., StapleyE. O., JacksonM.11 other authors1969; Phosphonomycin, a new antibiotic produced by strains of streptomyces. Science 166:122–123[CrossRef]
KempsellK. E., JiY. E., EstradaI. C., ColstonM. J., CoxR. A.1992; The nucleotide sequence of the promoter, 16S rRNA and spacer region of the ribosomal RNA operon of Mycobacterium tuberculosis and comparison with Mycobacterium leprae precursor rRNA. J Gen Microbiol 138:1717–1727[CrossRef]
KimD. H., LeesW. J., KempsellK. E., LaneW. S., DuncanK., WalshC. T.1996; Characterization of a Cys115 to Asp substitution in the cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin. Biochemistry 35:4923–4928[CrossRef]
KumarD., SrivastavaB. S., SrivastavaR.1998; Genetic rearrangements leading to disruption of heterologous gene expression in mycobacteria: an observation with Escherichia coli beta-galactosidase in Mycobacterium smegmatis and its implication in vaccine development. Vaccine 16:1212–1215[CrossRef]
MahenthiralingamE., DraperP., DavisE. O., ColstonM. J.1993; Cloning and sequencing of the gene which encodes the highly inducible acetamidase of Mycobacterium smegmatis. J Gen Microbiol 139:575–583[CrossRef]
O’GaoraP., BarniniS., HaywardC., FilleyE., RookG., YoungD., TholeJ.1997; Mycobacteria as immunogens: development of expression vectors for use in multiple mycobacterial species. Med Princ Pract 6:91–96
Pablos-MendezA., RaviglioneM. C., LaszloA.8 other authors1998; Global surveillance for antituberculosis-drug resistance, 1994–1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 338:1641–1649[CrossRef]
SkarzynskiT., MistryA., WonacottA., HutchinsonS. E., KellyV. A., DuncanK.1996; Structure of UDP-N-acetylglucosamine enolpyruvyl transferase, an enzyme essential for the synthesis of bacterial peptidoglycan, complexed with substrate UDP-N-acetylglucosamine and the drug fosfomycin. Structure 4:1465–1474[CrossRef]
TakiffH. E., CiminoM., MussoM. C., WeisbrodT., MartinezR., DelgadoM. B., SalazarL., BloomB. R., JacobsW. R.Jr1996; Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis. Proc Natl Acad Sci USA 93:362–366[CrossRef]
TriccasJ. A., ParishT., BrittonW. J., GicquelB.1998; An inducible expression system permitting the efficient purification of a recombinant antigen from Mycobacterium smegmatis. FEMS Microbiol Lett 167:151–156[CrossRef]
Alteration of a single amino acid residue reverses fosfomycin resistance of recombinant MurA from Mycobacterium tuberculosisThe EMBL accession number for the sequence in this paper is X96711.